Sign In
Buy INCY
$97.98
+5.74 (+6.22%)
At Close: Jun 03, 2026
Incyte Corporation Being Investigated on Behalf of Incyte Corporation Investors. Contact Levi & Korsinsky For Details.
07:30am, Wednesday, 04'th Dec 2024
NEW YORK, NY / ACCESSWIRE / December 4, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Incyte Corporation ("Incyte Corporation") (NASDAQ:INCY) concerning possible
Lost Money on Incyte Corporation(INCY)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
08:00am, Friday, 29'th Nov 2024
NEW YORK, NY / ACCESSWIRE / November 29, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Incyte Corporation ("Incyte Corporation") (NASDAQ:INCY) concerning possibl
Why Is Incyte (INCY) Up 2.1% Since Last Earnings Report?
12:35pm, Thursday, 28'th Nov 2024
Incyte (INCY) reported earnings 30 days ago. What's next for the stock?
Incyte Announces Updated Presentation Time for Upcoming Investor Conference
04:10pm, Tuesday, 26'th Nov 2024
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it will now present at Citi's 2024 Global Healthcare Conference on Tuesday, December 3, 2024 at 8:00 a.m. The presentation
INCY ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Incyte Corporation investment
07:25am, Tuesday, 26'th Nov 2024
NEW YORK, NY / ACCESSWIRE / November 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Incyte Corporation ("Incyte Corporation") (NASDAQ:INCY) concerning possibl
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY #ASH24--Incyte to Spotlight New Data, Including a Late Breaking Oral Presentation for Tafasitamab in Follicular Lymphoma, at the 2024 ASH Annual Meeting.
ATTENTION Incyte Corporation Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights
07:30am, Monday, 25'th Nov 2024
NEW YORK, NY / ACCESSWIRE / November 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Incyte Corporation ("Incyte Corporation") (NASDAQ:INCY) concerning possibl
INCY ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Incyte Corporation investment
07:30am, Thursday, 21'st Nov 2024
NEW YORK, NY / ACCESSWIRE / November 21, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Incyte Corporation ("Incyte Corporation") (NASDAQ:INCY) concerning possibl
Lost Money on Incyte Corporation(INCY)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
04:30pm, Tuesday, 19'th Nov 2024
NEW YORK, NY / ACCESSWIRE / November 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Incyte Corporation ("Incyte Corporation") (NASDAQ:INCY) concerning possibl
Incyte Pauses Enrollment in Chronic Spontaneous Urticaria Study
02:55pm, Tuesday, 19'th Nov 2024
INCY stops enrollment in the phase II study of MRGPRX2 in CSU after making certain in vivo preclinical toxicology discoveries.
Incyte Stock Slumps After Firm Scraps Drug, Pauses Enrollment in Other Study
12:51pm, Tuesday, 19'th Nov 2024
Incyte (INCY) led S&P 500 decliners Tuesday afternoon after the pharmaceutical firm said it will stop developing one drug and pause enrollment in the study of another.
Incyte Is the S&P 500's Worst Performer Today. What's Hitting the Stock.
12:21pm, Tuesday, 19'th Nov 2024
The biopharmaceutical company provided disappointing updates on two research studies.
Incyte's $750 Million Escient Deal Faces Setback With Toxicology Issues In Two Investigational Drugs, Analyst Flags Challenges
12:18pm, Tuesday, 19'th Nov 2024
On Monday, Incyte Corporation INCY announced that it will pause enrollment in the ongoing Phase 2 study of MRGPRX2 (INCB000262) in chronic spontaneous urticaria (CSU).
Incyte Collapses. Why Its $750 Million Escient Acquisition Now Looks Shattered.
09:23am, Tuesday, 19'th Nov 2024
Incyte stock tumbled Tuesday after the company scrapped one drug and paused enrollment in the study of another. The post Incyte Collapses.
Incyte Provides Update on Early Phase MRGPRX2 and MRGPRX4 Programs
04:30pm, Monday, 18'th Nov 2024
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Provides Update on Early Phase MRGPRX2 and MRGPRX4 Programs.
